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ABSTRACT
The Human Genome Variation database of Geno-
type to Phenotype information (HGVbaseG2P) is a
new central database for summary-level findings
produced by human genetic association studies,
both large and small. Such a database is needed
so that researchers have an easy way to access all
the available association study data relevant to their
genes, genome regions or diseases of interest. Such
a depository will allow true positive signals to be
more readily distinguished from false positives
(type I error) that fail to consistently replicate. In
this paper we describe how HGVbaseG2P has
been constructed, and how its data are gathered
and organized. We present a range of user-friendly
but powerful website tools for searching, browsing
and visualizing G2P study findings. HGVbaseG2P
is available at http://www.hgvbaseg2p.org.
INTRODUCTION
Genetic association studies provide a means to explore
the genetic basis of complex traits, such as disease and
drug response. Recent improvements in genotyping tech-
nologies and in sample biobanking have dramatically
increased the scale and the accuracy of the data being
produced. The reporting of results from such studies is,
however, far from optimal; they are typically dissemi-
nated in diverse and disconnected databases, journals
and meetings. Negative studies are all too often not
reported at all (1). Consequently, there is no convenient
way to gather together, compare and contrast ﬁndings
from comprehensive subsets of related studies. This pres-
ents a major problem for the ﬁeld, since association stud-
ies produce both positive and negative signals that may
be real or false, and which can only be resolved by com-
paring independently generated data sets. The situation
is further compounded by the recent emergence of large
genome-wide association studies (GWAS) data sets,
which involve the study of many thousands of subjects.
For example, in the past year alone, NHGRI’s GWA
catalogue (http://www.genome.gov/26525384) lists over
100 studies for dozens of diseases and traits. These
enormous studies bring extra complications with respect
to data handling, data sensitivity and statistical
interpretation.
The association study ﬁeld thus requires new and eﬀec-
tive means for helping researchers locate and compare
existing data relevant to their disease or gene of interest,
in an environment wherein negative studies can be
reported as easily and quickly as positive studies. Public
databases of genetic association data provide an obvious
potential solution to this problem, especially if data
deposition were encouraged by research-funding agencies
and scientiﬁc journals. Two archival databases of this
type do exist, namely dbGaP (http://www.ncbi.nlm.nih.
gov/sites/entrez?db=gap) (2) and EGA (http://www.ebi.
ac.uk/ega/), as do a few small disease-speciﬁc initia-
tives (3–5). However, none of these bring together a
globally comprehensive list of GWAS studies in a plat-
form designed to also receive direct submission of any
number of smaller studies. To provide the ﬁeld with
this missing capability, we recently released the Human
Genome Variation Genotype to Phenotype database
(HGVbaseG2P).
HGVbaseG2P represents the world’s ﬁrst central data-
base for summary-level (i.e. not person-speciﬁc) genetic
association data concerning any and all traits. It has
been populated with an initial series of GWAS data sets
acquired from other public depositories, and we will keep
this section of the database current whilst also receiving
result sets from the global research community. As
described in this report, to enable these data sets to be
eﬀectively integrated and optimally used, HGVbaseG2P
provides extensive web-based tools for result set browsing,
visualization and mining.
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HGVbaseG2P has evolved out of the polymorphism data-
base HGVbase (6). In addition to extending its predeces-
sor’s scope to include phenotypes (in patient and control
groups) and genotype–phenotype relationships (in the
form of association study ﬁndings), HGVbaseG2P com-
bines the best features of a database and a scientiﬁc
journal, i.e. free access to structured and comprehensive
result sets, along with summary-level presentation of
high-quality information with full author accreditation.
At the very least, the project aims to reduce hurdles to
data publication and so minimize the problems of pub-
lication bias (7), and it is designed to bring together
many diﬀerent data sets for joint analysis thereby helping
researchers identify genotyping artefacts and elucidate
association signals that are population-speciﬁc or shared
across related traits.
The data model underpinning HGVbaseG2P closely
follows that of the new PaGE object model standard
(http://www.pageom.org/). A detailed representation of
the HGVbaseG2P model is available at the database
website, and the principal elements of this are illustrated
in Figure 1. As is shown, summary-level association data
are layered on top of a foundational list of DNA variation
markers. This ‘Marker’ layer currently comprises core
information on all the markers presently in NCBI’s
dbSNP database (8) along with a direct link back to the
source for each marker. Additional marker lists will be
incorporated from other public databases, in particular
copy-number variants which are becoming widely used
in disease studies (9). Markers retain their source database
identiﬁers and are also assigned stable HGVbaseG2P IDs.
Changes to marker information in the source database
are tracked and updated in HGVbaseG2P via purpose
built software that appropriately handles marker and
allele content alterations, mergers and deletions in a way
that ensures the integrity of any existing connections to
frequency or association record items.
The main association data layer of HGVbaseG2P com-
prises four principal components that emulate the main
concepts used in standard literature reporting of genetic
association studies, namely ‘Study’, ‘Sample’, ‘Phenotype’
and ‘Experiment’ entities.
Studies
A ‘Study’ entity sits atop, and thereby integrates, the
three other main data entities that make up a single sub-
mission (‘Sample’, ‘Phenotype’ and ‘Experiment’). Each
‘Study’ entry could potentially include information
items such as ‘Authors’, ‘Title’, ‘Abstract’, ‘Objectives’
and ‘Conclusions’, plus various details relating to the
study design, and each will provide links to its original
data source so that further information and individual
level data can be requested.
Samples
HGVbaseG2P uses the ‘Sample Panel’ concept to repre-
sent a named collection of individuals that are employed
in a ‘Study’—such as disease cases, or matched controls.
Typically, individuals in a ‘Sample Panel’ are aﬀected by
one or more similar disease phenotypes, or have some
other key metric in common (e.g. age, gender, ethnicity).
Data generated by performing genotyping experiments are
reported in terms of an ‘Assayed Panel’. This is a group
of test subjects derived by splitting and/or merging one or
more sample panels to create new collections, on the basis
of some explicit criteria such as severity or subclass of
disease or some environmental criteria.
Phenotypes
Phenotypes are stored in a very ﬂexible but straightfor-
ward data structure. Whereas other databases typically
use unstructured free-text descriptions to hold pheno-
type information, HGVbaseG2P splits phenotype infor-
mation into three sub-components: (i) the ‘Phenotype
Property’ which represents the character or trait investi-
gated (e.g. nose size); (ii) the ‘Phenotype Method’ which
describes how the trait was measured (e.g. nasal septum
measured in centimetre to ﬁrst decimal place with a ruler);
and (iii) the ‘Phenotype Value’, which is a particular result
produced by measuring the trait using the described
method (e.g. size of nose=1.7cm). Identical ordinal or
nominal values in groups of individuals are thereby easily
represented, as are categories of disease aﬀection status.
For quantitative traits in patient groups, statistical values
that describe a distribution (e.g. median, standard devia-
tion, maximum, minimum) are stored as a series of
‘Phenotype Values’. The same data model allows pheno-
type thresholds to be speciﬁed and used as criteria for
‘Assayed Panel’ selection (e.g. weight greater than
‘Phenotype Value=120 kg’).
Experiments
‘Experiments’ are individual sections of a study sub-
mission, and each is constrained to a consideration of at
most one phenotype examined in a speciﬁc set of ‘Assayed
Panels’ (e.g. one case and one control ‘Assayed Panel’
Figure 1. Overview data model of HGVbaseG2P. The main subdivi-
sions of data that make up an association report are shown, with
further explanation of each component provided in the body text.
These components are illustrated sitting on top of a comprehensive
‘Marker’ layer which is pre-built and provides a common foundation
that all data submissions are directly connected into.
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type block in causing one phenotype). Subtypes include
‘Genotyping Experiments’ (holding marker allele and
genotype frequency data) and ‘Analysis Experiments’
(holding marker to trait association P-value data). The
‘Genotyping Experiments’ will become increasingly
useful as a reference of marker frequencies in a range of
populations as this data accumulate. Presently, however,
we only permit access to aggregate allele or genotype fre-
quency data one marker at a time, to avoid any risk of
individual identiﬁcation (10). The ‘Analysis Experiments’
are most central to the purpose of HGVbaseG2P, and
the data for each distinct experiment may include more
than one package of information based upon diﬀerent
statistical tests, such as an allelic trend test, a genotypic
test, etc. This information will usually be initially gener-
ated as an output ﬁle from software such as PLINK (11).
EXPLORING HGVBASEG2P CONTENT
In addition to establishing a large depository of summary-
level association data, an emphatic goal of HGVbaseG2P
is that of providing a powerful toolkit via which the
extensive database content can be explored so that new
knowledge may be created.
Graphical displayof association study data
To oﬀer an advanced visual means for accessing
HGVbaseG2P content, we have utilized open-source soft-
ware components from the Generic Model Organism
Database project (GMOD; http://gmod.org) and conﬁg-
ured/extended these to create novel genome-wide displays
of association study ﬁndings. From these views users can
then navigate onwards to far higher-resolution views pro-
vided via a region-level genome browser. This functionality
is illustrated in Figure 2. These graphical displays can be
reached by clicking on links provided within each ‘Analysis
Experiment’ description, or by going straight to the main
Genome View tab shown above every page view of a
‘Study’.
The genome browser capabilities of HGVbaseG2P
have been made even more powerful still by using DAS
technology—a lightweight network protocol for exchan-
ging genome annotations (12). This enables external
browsers that support DAS, such as Ensembl (13)
(http://www.ensembl.org), to retrieve HGVbaseG2P data
and display them as a third-party annotation track. Direct
links are available from region-level genome browser
views that open an Ensembl browser interface with a
matching HGVbaseG2P data track already loaded.
Text-based browsingand searching
To assist users in locating particular studies of interest, we
oﬀer several alternatives. Most simply, users can enter
boolean keyword search terms in search boxes provided
on the home page, which trigger broad searches of the
‘Study’, ‘Phenotype’ or ‘Marker’ sections of the database.
These searches return a list of all the ‘Study’ entries
that contain the search term(s), with each ‘Study’ ID
representing a link that will take the user to further
textual and graphical information about that ‘Study’.
Alternatively, one can search from the second-highest
level pages in the database, which focus on ‘Study’, ‘Phe-
notype’ and ‘Marker’ information. These pages employ a
user interface paradigm known as ‘faceted browsing’ (14).
The relevant data items for these pages are listed on the
right-hand side in a table or a series of panels, while
the left-hand side of the page provides ﬁltering options
by which users can narrow down the set of items shown.
Again, the objective is to identify one or more ‘Study’
entries of interest, to then follow their ID links to see
further details on each.
Data mining
The browsing and visualization tools described above
enable users to locate and then explore single ‘Study’
details. Complex data mining challenges, however, may
need to query across almost all the database content
and deliver complex result sets. This capability is enabled
via the HGVmart tool, which is based upon another
GMOD component—the BioMart system (15) (http://
www.biomart.org). HGVmart functions are provided via
a high-level page in the database website (derived from
the standard MartView interface), as well as by means
of a web service which enables programmatic query and
retrieval, plus access from analysis workﬂow tools such
as myGrid’s Taverna (16) and Galaxy (17).
Gatheringassociation datafor HGVbaseG2P
Genetic association datasets are incorporated into
HGVbaseG2P without any subjective evaluation of
‘importance’ of the study ﬁndings. This is central to our
mission of providing a comprehensive and unbiased
summary of the relationship between DNA variation
and human phenotypic traits. At the time of writing
(September 2008), the database is capable of holding
summary-level case-control data sets for dichotomous
or quantitative traits of any size or complexity. The cur-
rent catalogue comprises 14 GWAS data sets spanning
12 diseases, with this initial content sourced with permis-
sion from the National Cancer Institute CGEMS project
(http://cgems.cancer.gov), dbGaP, the Wellcome Trust
Case-Control Consortium(WTCCC) (18) and the Broad
Institute’s Diabetes Genetics initiative (http://www.
broad.mit.edu/diabetes/). This collection will be continu-
ally expanded by HGVbaseG2P curators who have
identiﬁed several hundred additional data sets (mostly
GWAS) that are now, or soon will be, publicly available.
Before incorporation into HGVbaseG2P, the gathered
data are checked to ensure that the utilized marker IDs
are valid, that the reported alleles match known alleles
for the marker in terms of sequence and DNA strand,
that male and female genotype data are properly repre-
sented for X chromosome markers, and that the total
association data set is complete and internally consistent.
HGVbaseG2P welcomes and encourages the direct sub-
mission of data sets from the general community, includ-
ing the results of large-scale projects such as GWAS,
and smaller eﬀorts such as those designed to test indi-
vidual genes, ﬁne-map regions or replicate previously
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we are building submission software that will guide users
through the process of specifying and packaging their
data, thereafter providing a means for direct submission
to our curation pipeline and into the database. These
developments will be supported by approaching funding
agencies and scientiﬁc journals to request their help in
encouraging data submissions to projects like HGV
baseG2P.
FUTURE DEVELOPMENTS
There are many ways in which HGVbase can be
further developed. The underlying data model itself is
quite ‘future-proof’, in that it can handle multi-marker
associations, haplotype data and complex genotype
classes—such as non-diploid genotypes and allele signals
that may be quantitative or expressed as ratios, as needed
for copy number variants. We will therefore be able to
quickly incorporate these kinds of data as they become
available. Ongoing work to extend the model will provide
support for odds ratio data and alternative experimental
designs (e.g. family-based association testing), and in
conjunction with this the visualization capabilities will
be suitably extended. Additional work on the genome
browser is aimed at enabling researchers to view multiple
sets of results simultaneously, thereby enhancing the
potential for cross-study comparison and integration.
Furthermore, the ability to export association data
Figure 2. HGVbaseG2P graphical display capabilities. Screenshots are provided that show data from a Type 1 diabetes disease association data set
produced by the WTCCC. The histogram alongside each chromosome indicates the number (linear or logarithmic scaling options) of markers per
3Mbp bin having a P-value that passes a tunable signiﬁcance threshold. A bin with 20 signiﬁcant markers is apparent at 9p21. Clicking on this
region zooms in to a dynamic image (i.e. scale and position may be tailored to one’s preferences) presented in a region-level browser via which the
user can access optional tracks for individual marker associations, count of signiﬁcant markers and P-value of most signiﬁcant marker within various
resolution bins, known genes details and other common annotations.
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grate with the UCSC browser (19).
In all probability, an increasing number of data-
bases like HGVbaseG2P will start to appear across
the Internet in the near future (Thorisson, Muilu and
Brookes, submitted). These may, like HGVbaseG2P, be
designed to act as a central warehouse, or they might
serve to disseminate data sets of interest to speciﬁc labora-
tories, institutes, consortia, societies, companies, journals
or countries. It will then be highly desirable to seamlessly
network these depositories into a global federated system,
enabling them all to be searched from many diﬀerent
interfaces. This will be relatively easy to achieve if the
anticipated databases all utilize common data models,
such as PaGE-OM or that of HGVbaseG2P. Indeed,
this concept lies at the heart of the GEN2PHEN project
(http://www.gen2phen.org), of which HGVbaseG2P is a
part, and to promote this our complete database imple-
mentation is freely available as open-source software.
In time, this federated system can be expected to make
use of increasingly powerful Grid technologies and the
semantic web. HGVbaseG2P will be adapted accordingly,
and our ﬁrst steps in this direction are reﬂected in our
use of the BioMart system.
SYSTEM DESIGN AND IMPLEMENTATION
Database and middleware
HGVbaseG2P is implemented as a traditional relational
database using the open-source MySQL platform (http://
www.mysql.com). Data import/export tools and data-
base middleware components are all implemented in the
Perl programming language, leveraging a number of open-
source software packages from the Comprehensive Perl
Archive Network (CPAN, http://www.cpan.org).
Website
The HGVbaseG2P web application is built using the
Perl-based Catalyst MVC-framework (http://www.cata
lystframework.org). Genome viewer tools are based
primarily on two GMOD components, the Generic
Genome Browser (20) (http://gmod.org/wiki/GBrowse)
and GBrowse karyotype (http://gmod.org/wiki/GBrowse
_karyotype), with the Bio::DB::SeqFeature::Store feature
database from the Bioperl toolkit (21) (http://www.bio
perl.org) forming the back end. Web pages with faceted
browsing use client-side Javascript code from the
SIMILE Exhibit project (22) (http://simile.mit.edu/
exhibit/). Lastly, the full-text search engine on the website
was built with the open-source Xapian toolkit (http://
www.xapian.org).
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